MRSN vs NXPI · rev $40.5M vs P/E 29, rev $12.27B
Mersana Therapeutics Inc (MRSN) versus NXP Semiconductors NV (NXPI) — a side-by-side from cached financials, not a winner call.
Mersana Therapeutics Inc (MRSN) is a biotechnology company listed on NASDAQ.
NXP Semiconductors NV (NXPI) is a semiconductors company listed on NASDAQ.
Latest reported MRSN revenue for 2024-12-31 was $40.5M. Net income was -$69.2M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. MRSN currently screens at market cap $145.4M.
Latest reported NXPI revenue for 2025-12-31 was $12.27B. Net income was $2.02B. Revenue was down 2.7% from 2024-12-31 to 2025-12-31. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
MRSN currently screens at market cap $145.4M. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
Not investment advice. Open the MRSN and NXPI stock pages for the full models.
Not investment advice.